Antioxidant Effects of Lutein in Neonatal Period

Abstract

During fetal life, a right balance between oxidants and antioxidants is required for survival and growth of the fetus. At birth, an overproduction of free radicals (FRs) together with poor antioxidant defenses may be detrimental for developing organs and tissues. Protecting the newborn infant against perinatal oxidative stress (OS) is a health care priority, and therefore the search for new, safe, and efficacious antioxidants has been a major quest during the last decade. Due to its antioxidant and anti-inflammatory properties, lutein, a compound belonging to the xanthophyll family of carotenoids, is one of the most promising molecules with clinical application during neonatal age. Lutein is not synthesized by humans, hence the intake primarily depends on diet. In the neonatal period, fresh human milk is the main source of lutein, though lutein-enriched infant formulas are now available. Oral supplementation represents an alternative source of lutein, and it has been demonstrated to decrease plasma biomarkers of OS and increase antioxidant capacity in the first days of life.

Keywords

oxidative stress - free radicals - reactive oxygen species - lutein

• References

• 1 Khachik F, Beecher GR, Goli MB, Lusby WR, Smith Jr JC. Separation and identification of carotenoids and their oxidation products in the extracts of human plasma. Anal Chem 1992; 64 (18) 2111-2122
• 2 Khachik F, Beecher GR, Goli MB, Lusby WR. Separation and quantitation of carotenoids in foods. Methods Enzymol 1992; 213: 347-359
• 3 Khachik F, Beecher GR, Goli MB, Lusby WR, Daitch CE. Separation and quantification of carotenoids in human plasma. Methods Enzymol 1992; 213: 205-219
• 4 Widomska J, Subczynski WK. Why has nature chosen lutein and zeaxanthin to protect the retina?. J Clin Exp Ophthalmol 2014; 5 (1) 326
• 5 Buonocore G, Tei M, Perrone S. Lutein as protective agent against neonatal oxidative stress. J Pediatr Neonat Individual Med 2014; 3 (2) e030244
• 6 Martin HD, Ruck C, Schmidt M , et al. Chemistry of carotenoid oxidation and free radical reactions. Pure Appl Chem 1999; 71: 2253-2262
• 7 Böhm F, Edge R, Truscott TG. Interactions of dietary carotenoids with singlet oxygen (1O2) and free radicals: potential effects for human health. Acta Biochim Pol 2012; 59 (1) 27-30
• 8 Edge R, McGarvey DJ, Truscott TG. The carotenoids as anti-oxidants – a review. J Photochem Photobiol B 1997; 41 (3) 189-200
• 9 Alves-Rodrigues A, Shao A. The science behind lutein. Toxicol Lett 2004; 150 (1) 57-83
• 10 Kalariya NM, Ramana KV, Srivastava SK, van Kuijk FJ. Post-translational protein modification by carotenoid cleavage products. Biofactors 2011; 37 (2) 104-116
• 11 Kalariya NM, Ramana KV, Vankuijk FJ. Focus on molecules: lutein. Exp Eye Res 2012; 102: 107-108
• 12 Bernstein PS, Li B, Vachali PP , et al. Lutein, zeaxanthin, and meso-zeaxanthin: the basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease. Prog Retin Eye Res 2016; 50: 34-66
• 13 Sujak A, Gabrielska J, Grudziński W, Borc R, Mazurek P, Gruszecki WI. Lutein and zeaxanthin as protectors of lipid membranes against oxidative damage: the structural aspects. Arch Biochem Biophys 1999; 371 (2) 301-307
• 14 Rosenthal JM, Kim J, de Monasterio F , et al. Dose-ranging study of lutein supplementation in persons aged 60 years or older. Invest Ophthalmol Vis Sci 2006; 47 (12) 5227-5233
• 15 Whitehead AJ, Mares JA, Danis RP. Macular pigment: a review of current knowledge. Arch Ophthalmol 2006; 124 (7) 1038-1045
• 16 Izumi-Nagai K, Nagai N, Ohgami K , et al. Macular pigment lutein is antiinflammatory in preventing choroidal neovascularization. Arterioscler Thromb Vasc Biol 2007; 27 (12) 2555-2562
• 17 Sasaki M, Ozawa Y, Kurihara T , et al. Neuroprotective effect of an antioxidant, lutein, during retinal inflammation. Invest Ophthalmol Vis Sci 2009; 50 (3) 1433-1439
• 18 Kijlstra A, Tian Y, Kelly ER, Berendschot TT. Lutein: more than just a filter for blue light. Prog Retin Eye Res 2012; 31 (4) 303-315
• 19 O'Neill ME, Carroll Y, Corridan B , et al. A European carotenoid database to assess carotenoid intakes and its use in a five-country comparative study. Br J Nutr 2001; 85 (4) 499-507
• 20 Mangels AR, Holden JM, Beecher GR, Forman MR, Lanza E. Carotenoid content of fruits and vegetables: an evaluation of analytic data. J Am Diet Assoc 1993; 93 (3) 284-296
• 21 Sommerburg O, Keunen JE, Bird AC, van Kuijk FJ. Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes. Br J Ophthalmol 1998; 82 (8) 907-910
• 22 Yeum KJ, Ferland G, Patry J, Russell RM. Relationship of plasma carotenoids, retinol and tocopherols in mothers and newborn infants. J Am Coll Nutr 1998; 17 (5) 442-447
• 23 Bettler J, Zimmer JP, Neuringer M, DeRusso PA. Serum lutein concentrations in healthy term infants fed human milk or infant formula with lutein. Eur J Nutr 2010; 49 (1) 45-51
• 24 Tacken KJ, Vogelsang A, van Lingen RA, Slootstra J, Dikkeschei BD, van Zoeren-Grobben D. Loss of triglycerides and carotenoids in human milk after processing. Arch Dis Child Fetal Neonatal Ed 2009; 94 (6) F447-F450
• 25 Perrone S, Negro S, Tataranno ML, Buonocore G. Oxidative stress and antioxidant strategies in newborns. J Matern Fetal Neonatal Med 2010; 23 (Suppl. 03) 63-65
• 26 Halliwell B. Reactive species and antioxidants. Redox biology is a fundamental theme of aerobic life. Plant Physiol 2006; 141 (2) 312-322
• 27 Perrone S, Salvi G, Bellieni CV, Buonocore G. Oxidative stress and nutrition in the preterm newborn. J Pediatr Gastroenterol Nutr 2007; 45 (Suppl. 03) S178-S182
• 28 Perrone S, Vezzosi P, Longini M , et al. Biomarkers of oxidative stress in babies at high risk for retinopathy of prematurity. Front Biosci (Elite Ed) 2009; 1: 547-552
• 29 Perrone S, Mussap M, Longini M , et al. Oxidative kidney damage in preterm newborns during perinatal period. Clin Biochem 2007; 40 (9–10) 656-660
• 30 Perrone S, Tataranno ML, Santacroce A, Negro S, Buonocore G. The role of oxidative stress on necrotizing enterocolitis in very low birth weight infants. Curr Pediatr Rev 2014; 10 (3) 202-207
• 31 Perrone S, Tataranno ML, Buonocore G. Oxidative stress and bronchopulmonary dysplasia. J Clin Neonatol 2012; 1 (3) 109-114
• 32 Perrone S, Tataranno ML, Stazzoni G, Del Vecchio A, Buonocore G. Oxidative injury in neonatal erythrocytes. J Matern Fetal Neonatal Med 2012; 25 (Suppl. 05) 104-108
• 33 Perrone S, Tataranno ML, Negro S , et al. Early identification of the risk for free radical-related diseases in preterm newborns. Early Hum Dev 2010; 86 (4) 241-244
• 34 Bhosale P, Bernstein PS. Quantitative measurement of 3′-oxolutein from human retina by normal-phase high-performance liquid chromatography coupled to atmospheric pressure chemical ionization mass spectrometry. Anal Biochem 2005; 345 (2) 296-301
• 35 Sommerburg O, Meissner K, Nelle M, Lenhartz H, Leichsenring M. Carotenoid supply in breast-fed and formula-fed neonates. Eur J Pediatr 2000; 159 (1–2) 86-90
• 36 Perrone S, Longini M, Marzocchi B , et al. Effects of lutein on oxidative stress in the term newborn: a pilot study. Neonatology 2010; 97 (1) 36-40
• 37 Perrone S, Tei M, Longini M , et al. Lipid and protein oxidation in newborn infants after lutein administration. Oxid Med Cell Longev 2014; 2014: 781454
• 38 Rivera JC, Sapieha P, Joyal JS , et al. Understanding retinopathy of prematurity: update on pathogenesis. Neonatology 2011; 100 (4) 343-353
• 39 Ates O, Alp HH, Caner I , et al. Oxidative DNA damage in retinopathy of prematurity. Eur J Ophthalmol 2009; 19 (1) 80-85
• 40 Hartnett ME. The effects of oxygen stresses on the development of features of severe retinopathy of prematurity: knowledge from the 50/10 OIR model. Doc Ophthalmol 2010; 120 (1) 25-39
• 41 Romagnoli C, Giannantonio C, Cota F , et al. A prospective, randomized, double blind study comparing lutein to placebo for reducing occurrence and severity of retinopathy of prematurity. J Matern Fetal Neonatal Med 2011; 24 (Suppl. 01) 147-150
• 42 Dani C, Lori I, Favelli F , et al. Lutein and zeaxanthin supplementation in preterm infants to prevent retinopathy of prematurity: a randomized controlled study. J Matern Fetal Neonatal Med 2012; 25 (5) 523-527
• 43 Manzoni P, Guardione R, Bonetti P , et al. Lutein and zeaxanthin supplementation in preterm very low-birth-weight neonates in neonatal intensive care units: a multicenter randomized controlled trial. Am J Perinatol 2013; 30 (1) 25-32
• 44 Costa S, Giannantonio C, Romagnoli C , et al. Effects of lutein supplementation on biological antioxidant status in preterm infants: a randomized clinical trial. J Matern Fetal Neonatal Med 2013; 26 (13) 1311-1315
• 45 Lorenzoni F, Giampietri M, Ferri G , et al. Lutein administration to pregnant women with gestational diabetes mellitus is associated to a decrease of oxidative stress in newborns. Gynecol Endocrinol 2013; 29 (10) 901-903